Remotigue, Baby Girl .

HRN: 28-96-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2026
AMPICILLIN 250MG (VIAL)
05/10/2026
05/17/2026
IVT
125mg
Q12H
PSNB (Non-institutional Delivery)
Checking Initial Appropriateness 
05/10/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
05/10/2026
05/17/2026
IVT
10mg
Q24H
PSNB (Non-institutional Delivery)
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: